Front & Back Matter.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. N.PAG, doi. 10.1159/000502301
- Publication type:
- Article
Works matching IS 00303747 AND DT 2019 AND VI 62 AND IP 2
Results: 8
1
2
Diagnostic Performance of Retinopathy in the Detection of Diabetic Nephropathy in Type 2 Diabetes: A Systematic Review and Meta-Analysis of 45 Studies.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 68, doi. 10.1159/000500833
- By:
- Publication type:
- Article
3
Management and Systemic Implications of Diabetic Neovascular Glaucoma.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 111, doi. 10.1159/000500607
- By:
- Publication type:
- Article
4
One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 93, doi. 10.1159/000500118
- By:
- Publication type:
- Article
5
Comparison of Subconjunctival Aflibercept and Betamethasone for the Treatment of Formed Corneal Neovascularization in a Rabbit Model.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 116, doi. 10.1159/000499165
- By:
- Publication type:
- Article
6
Single-Field Non-Mydriatic Fundus Photography for Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 61, doi. 10.1159/000499106
- By:
- Publication type:
- Article
7
The Protective Roles of Folic Acid in Preventing Diabetic Retinopathy Are Potentially Associated with Suppressions on Angiogenesis, Inflammation, and Oxidative Stress.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 80, doi. 10.1159/000499020
- By:
- Publication type:
- Article
8
Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study.
- Published in:
- Ophthalmic Research, 2019, v. 62, n. 2, p. 101, doi. 10.1159/000497406
- By:
- Publication type:
- Article